Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

17.370
-0.530-2.96%
Volume:4.98M
Turnover:86.67M
Market Cap:46.19B
PE:11.72
High:17.800
Open:17.800
Low:17.180
Close:17.900
52wk High:28.232
52wk Low:14.505
Shares:2.66B
HK Float Shares:540.97M
Volume Ratio:1.02
T/O Rate:0.92%
Dividend:0.46
Dividend Rate:2.62%
EPS(LYR):1.482
ROE:7.04%
ROA:1.53%
PB:0.81
PE(LYR):11.72
PS:0.94

Loading ...

Fosun Pharma Subsidiary’s Tao Hong Si Wu Tang Granules Secures NMPA Filing Acceptance

Bulletin Express
·
May 13

FOSUN PHARMA's Application for Traditional Chinese Medicine New Drug Accepted for Review

Stock News
·
May 13

Shanghai Fosun Pharma - Drug Registration Applications of Tao Hong Si Wu Tang Granules by Unit Accepted by Nmpa China

THOMSON REUTERS
·
May 13

Fosun Pharma Releases 2026 AGM & Second H-Shareholders Meeting Circular; Offers Digital Access and Print Options

Bulletin Express
·
May 11

Fosun Pharma Calls 16 June 2026 H Shareholders Meeting to Seek 10% Dual-Class Buyback Mandates

Bulletin Express
·
May 11

Fosun Pharma Calls 16 June AGM to Vote on RMB0.39 Dividend, RMB35 Billion Guarantee Cap and New Financing Mandates

Bulletin Express
·
May 11

Fosun Pharma's Unit Gets Nod for Registration of Venlafaxine Hydrochloride Tablets

MT Newswires Live
·
May 11

Henlius Biotech Gets European Commission's Nod for Hetronifly

MT Newswires Live
·
May 11

FOSUN PHARMA's Biosimilar HLX05-N Receives FDA Clearance for US Clinical Trial

Stock News
·
May 10

Fosun Pharma Subsidiary Obtains NMPA Green Light for Venlafaxine Sustained-Release Tablets

Bulletin Express
·
May 08

FOSUN PHARMA's Venlafaxine Hydrochloride Extended-Release Tablets Receive Market Approval

Stock News
·
May 08

Shanghai Fosun Pharma - Drug Registration Application for Venlafaxine Hydrochloride Sustained-Release Tablets Approved by China's Nmpa

THOMSON REUTERS
·
May 08

Sinopharm Group Stock Sheds 1.6% in Hong Kong

Dow Jones
·
May 08

Leadership Reshuffle Sweeps Pharmaceutical Sector: Hengrui, Fosun, AstraZeneca, Pfizer Among Key Players

Deep News
·
May 07

Shanghai Fosun Pharma - Drug Registration Application for Sodium Nitroprusside Injection Approved by Nmpa

THOMSON REUTERS
·
Apr 30

Fosun Pharma Maintains Stable Share Base in April; 0% New Issuance, Public Float Compliant

Bulletin Express
·
Apr 30

FOSUN PHARMA Subsidiary Receives Regulatory Approval for Sodium Nitroprusside Injection

Stock News
·
Apr 30

Fosun Pharmaceutical Reports 14% Higher Profit in Q1

MT Newswires Live
·
Apr 29

Press Release: Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution

Dow Jones
·
Apr 28

Morgan Stanley Raises Fosun Pharma's Revenue Forecast, Sets HK$32 Target with "Overweight" Rating

Stock News
·
Apr 22